Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.25B |
| 2 |
Charles Schwab
SCHW
|
+$588M |
| 3 |
Microsoft
MSFT
|
+$511M |
| 4 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$461M |
| 5 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$434M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.15B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.12B |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$652M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$428M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$395M |
Sector Composition
| 1 | Technology | 18.42% |
| 2 | Consumer Discretionary | 11.17% |
| 3 | Financials | 10.9% |
| 4 | Healthcare | 8.48% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAD
2851
Allspring Income Opportunities Fund
EAD
$419M
| $342K | ﹤0.01% |
41,839
+22,480
| +116% | +$184K |
|
2852
ICF International
ICFI
$1.78B
| $342K | ﹤0.01% |
4,597
+3,350
| +269% | +$249K |
|
2853
Marten Transport
MRTN
$915M
| $342K | ﹤0.01% |
19,873
+12,371
| +165% | +$213K |
|
|
WW
2854
DELISTED
WW International
WW
| $342K | ﹤0.01% |
14,008
+5,520
| +65% | +$135K |
|
|
RAVN
2855
DELISTED
Raven Industries Inc
RAVN
| $342K | ﹤0.01% |
10,334
-2,634
| -20% | -$87.2K |
|
2856
Midland States Bancorp
MSBI
$386M
| $341K | ﹤0.01% |
19,085
+9,630
| +102% | +$172K |
|
|
PCK
2857
DELISTED
Pimco California Municipal Income Fund II
PCK
| $340K | ﹤0.01% |
37,684
-3,800
| -9% | -$34.3K |
|
|
EGRX
2858
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $340K | ﹤0.01% |
7,305
-39
| -0.5% | -$1.82K |
|
|
BTWNU
2859
DELISTED
Bridgetown Holdings Limited Units
BTWNU
| $340K | ﹤0.01% |
+20,000
| New | +$340K |
|
2860
Provident Financial Services
PFS
$2.58B
| $339K | ﹤0.01% |
18,873
+13,359
| +242% | +$240K |
|
2861
Standard Motor Products
SMP
$883M
| $339K | ﹤0.01% |
8,395
+6,713
| +399% | +$271K |
|
2862
Goosehead Insurance
GSHD
$2.05B
| $338K | ﹤0.01% |
2,710
+1,939
| +251% | +$242K |
|
2863
TFS Financial
TFSL
$3.7B
| $338K | ﹤0.01% |
19,231
-12,555
| -39% | -$221K |
|
2864
Helios Technologies
HLIO
$1.78B
| $337K | ﹤0.01% |
6,327
+4,328
| +217% | +$231K |
|
2865
NatWest
NWG
$58B
| $337K | ﹤0.01% |
69,186
+6,263
| +10% | +$30.5K |
|
2866
Yext
YEXT
$1.08B
| $337K | ﹤0.01% |
21,419
+13,654
| +176% | +$215K |
|
|
HGEN
2867
DELISTED
HUMANIGEN, INC.
HGEN
| $337K | ﹤0.01% |
+19,268
| New | +$337K |
|
2868
Delek Logistics
DKL
$2.45B
| $336K | ﹤0.01% |
10,514
+953
| +10% | +$30.5K |
|
2869
Invesco Biotechnology & Genome ETF
PBE
$221M
| $336K | ﹤0.01% |
4,794
-100
| -2% | -$7.01K |
|
2870
AquaBounty Technologies
AQB
$4.42M
| $335K | ﹤0.01% |
+1,913
| New | +$335K |
|
2871
BRF SA
BRFS
$6.7B
| $335K | ﹤0.01% |
79,704
+7,992
| +11% | +$33.6K |
|
2872
SPDR MSCI ACWI ex-US ETF
CWI
$2.13B
| $335K | ﹤0.01% |
12,130
| – | – |
|
2873
National Bank Holdings
NBHC
$1.48B
| $335K | ﹤0.01% |
10,214
+6,570
| +180% | +$215K |
|
2874
S&T Bancorp
STBA
$1.47B
| $333K | ﹤0.01% |
13,383
+5,912
| +79% | +$147K |
|
2875
Olema Pharmaceuticals
OLMA
$532M
| $332K | ﹤0.01% |
+6,912
| New | +$332K |
|